+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neuromuscular Disease Therapeutics Market 2023-2027

  • PDF Icon

    Report

  • 163 Pages
  • October 2023
  • Region: Global
  • TechNavio
  • ID: 5547367
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The neuromuscular disease therapeutics market is forecasted to grow by USD 6513.28 million during 2022-2027, accelerating at a CAGR of 10.3% during the forecast period. The report on the neuromuscular disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by novel approvals for neuromuscular disease therapeutics, growing newborn screening tests, and huge unmet need for neuromuscular disease therapeutics.

The neuromuscular disease therapeutics market is segmented as below:

By Type

  • Biologics
  • Small molecules

By End-user

  • Hospitals
  • Clinics
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the technological advances in neuromuscular disease therapy as one of the prime reasons driving the neuromuscular disease therapeutics market growth during the next few years. Also, inherited nature of neuromuscular diseases and increasing research on developing therapeutics for neuromuscular disease will lead to sizable demand in the market.

The report on the neuromuscular disease therapeutics market covers the following areas:

  • Neuromuscular disease therapeutics market sizing
  • Neuromuscular disease therapeutics market forecast
  • Neuromuscular disease therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuromuscular disease therapeutics market vendors that include Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc., Brainstorm Cell Therapeutics Inc., Cytokinetics Inc., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Mitsubishi Chemical Corp., Mylan NV, Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer Inc., PTC Therapeutics Inc., Sanofi, Sarepta Therapeutics Inc, SGPharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Viatris Inc., and AFM-Telethon. Also, the neuromuscular disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary €“ Chart on Market Overview
Exhibit 02: Executive Summary €“ Data Table on Market Overview
Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
Exhibit 06: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary €“ Chart on Incremental Growth
Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global neuromuscular disease therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Biologics - Market size and forecast 2022-2027
Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
6.4 Small molecules - Market size and forecast 2022-2027
Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Clinics - Market size and forecast 2022-2027
Exhibit 52: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AFM-Telethon
Exhibit 111: AFM-Telethon - Overview
Exhibit 112: AFM-Telethon - Product/Service
Exhibit 113: AFM-Telethon - Key offerings
12.4 Aquestive Therapeutics Inc.
Exhibit 114: Aquestive Therapeutics Inc. - Overview
Exhibit 115: Aquestive Therapeutics Inc. - Business segments
Exhibit 116: Aquestive Therapeutics Inc. - Key offerings
Exhibit 117: Aquestive Therapeutics Inc. - Segment focus
12.5 Biogen Inc.
Exhibit 118: Biogen Inc. - Overview
Exhibit 119: Biogen Inc. - Product/Service
Exhibit 120: Biogen Inc. - Key offerings
12.6 Brainstorm Cell Therapeutics Inc.
Exhibit 121: Brainstorm Cell Therapeutics Inc. - Overview
Exhibit 122: Brainstorm Cell Therapeutics Inc. - Product/Service
Exhibit 123: Brainstorm Cell Therapeutics Inc. - Key offerings
12.7 F. Hoffmann La Roche Ltd.
Exhibit 124: F. Hoffmann La Roche Ltd. - Overview
Exhibit 125: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 126: F. Hoffmann La Roche Ltd. - Key news
Exhibit 127: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 128: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Ionis Pharmaceuticals Inc.
Exhibit 129: Ionis Pharmaceuticals Inc. - Overview
Exhibit 130: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 131: Ionis Pharmaceuticals Inc. - Key news
Exhibit 132: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 133: Ionis Pharmaceuticals Inc. - Segment focus
12.9 Mitsubishi Chemical Corp.
Exhibit 134: Mitsubishi Chemical Corp. - Overview
Exhibit 135: Mitsubishi Chemical Corp. - Business segments
Exhibit 136: Mitsubishi Chemical Corp. - Key offerings
Exhibit 137: Mitsubishi Chemical Corp. - Segment focus
12.10 Nippon Shinyaku Co. Ltd.
Exhibit 138: Nippon Shinyaku Co. Ltd. - Overview
Exhibit 139: Nippon Shinyaku Co. Ltd. - Business segments
Exhibit 140: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibit 141: Nippon Shinyaku Co. Ltd. - Segment focus
12.11 Novartis AG
Exhibit 142: Novartis AG - Overview
Exhibit 143: Novartis AG - Business segments
Exhibit 144: Novartis AG - Key offerings
Exhibit 145: Novartis AG - Segment focus
12.12 Pfizer Inc.
Exhibit 146: Pfizer Inc. - Overview
Exhibit 147: Pfizer Inc. - Product/Service
Exhibit 148: Pfizer Inc. - Key news
Exhibit 149: Pfizer Inc. - Key offerings
12.13 PTC Therapeutics Inc.
Exhibit 150: PTC Therapeutics Inc. - Overview
Exhibit 151: PTC Therapeutics Inc. - Product/Service
Exhibit 152: PTC Therapeutics Inc. - Key offerings
12.14 Sanofi
Exhibit 153: Sanofi - Overview
Exhibit 154: Sanofi - Business segments
Exhibit 155: Sanofi - Key news
Exhibit 156: Sanofi - Key offerings
Exhibit 157: Sanofi - Segment focus
12.15 Sarepta Therapeutics Inc
Exhibit 158: Sarepta Therapeutics Inc - Overview
Exhibit 159: Sarepta Therapeutics Inc - Product/Service
Exhibit 160: Sarepta Therapeutics Inc - Key offerings
12.16 SGPharma Pvt. Ltd.
Exhibit 161: SGPharma Pvt. Ltd. - Overview
Exhibit 162: SGPharma Pvt. Ltd. - Product/Service
Exhibit 163: SGPharma Pvt. Ltd. - Key offerings
12.17 Viatris Inc.
Exhibit 164: Viatris Inc. - Overview
Exhibit 165: Viatris Inc. - Business segments
Exhibit 166: Viatris Inc. - Key news
Exhibit 167: Viatris Inc. - Key offerings
Exhibit 168: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary €“ Chart on Market Overview
Exhibits 2: Executive Summary €“ Data Table on Market Overview
Exhibits 3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits 4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits 6: Executive Summary €“ Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary €“ Chart on Incremental Growth
Exhibits 8: Executive Summary €“ Data Table on Incremental Growth
Exhibits 9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size €“ Data Table on global neuromuscular disease therapeutics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size €“ Type Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size €“ End-user Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size €“ Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size €“ Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Type - Market share 2022-2027 (%)
Exhibits 31: Data Table on Type - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Type ($ million)
Exhibits 43: Data Table on Market opportunity by Type ($ million)
Exhibits 44: Chart on End-user - Market share 2022-2027 (%)
Exhibits 45: Data Table on End-user - Market share 2022-2027 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibits 52: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibits 54: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 55: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
Exhibits 56: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 58: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 59: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 60: Market opportunity by End-user ($ million)
Exhibits 61: Data Table on Market opportunity by End-user ($ million)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 87: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 88: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 89: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ million)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 105: Impact of drivers and challenges in 2022 and 2027
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: AFM-Telethon - Overview
Exhibits 112: AFM-Telethon - Product/Service
Exhibits 113: AFM-Telethon - Key offerings
Exhibits 114: Aquestive Therapeutics Inc. - Overview
Exhibits 115: Aquestive Therapeutics Inc. - Business segments
Exhibits 116: Aquestive Therapeutics Inc. - Key offerings
Exhibits 117: Aquestive Therapeutics Inc. - Segment focus
Exhibits 118: Biogen Inc. - Overview
Exhibits 119: Biogen Inc. - Product/Service
Exhibits 120: Biogen Inc. - Key offerings
Exhibits 121: Brainstorm Cell Therapeutics Inc. - Overview
Exhibits 122: Brainstorm Cell Therapeutics Inc. - Product/Service
Exhibits 123: Brainstorm Cell Therapeutics Inc. - Key offerings
Exhibits 124: F. Hoffmann La Roche Ltd. - Overview
Exhibits 125: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 126: F. Hoffmann La Roche Ltd. - Key news
Exhibits 127: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 128: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 129: Ionis Pharmaceuticals Inc. - Overview
Exhibits 130: Ionis Pharmaceuticals Inc. - Business segments
Exhibits 131: Ionis Pharmaceuticals Inc. - Key news
Exhibits 132: Ionis Pharmaceuticals Inc. - Key offerings
Exhibits 133: Ionis Pharmaceuticals Inc. - Segment focus
Exhibits 134: Mitsubishi Chemical Corp. - Overview
Exhibits 135: Mitsubishi Chemical Corp. - Business segments
Exhibits 136: Mitsubishi Chemical Corp. - Key offerings
Exhibits 137: Mitsubishi Chemical Corp. - Segment focus
Exhibits 138: Nippon Shinyaku Co. Ltd. - Overview
Exhibits 139: Nippon Shinyaku Co. Ltd. - Business segments
Exhibits 140: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibits 141: Nippon Shinyaku Co. Ltd. - Segment focus
Exhibits 142: Novartis AG - Overview
Exhibits 143: Novartis AG - Business segments
Exhibits 144: Novartis AG - Key offerings
Exhibits 145: Novartis AG - Segment focus
Exhibits 146: Pfizer Inc. - Overview
Exhibits 147: Pfizer Inc. - Product/Service
Exhibits 148: Pfizer Inc. - Key news
Exhibits 149: Pfizer Inc. - Key offerings
Exhibits 150: PTC Therapeutics Inc. - Overview
Exhibits 151: PTC Therapeutics Inc. - Product/Service
Exhibits 152: PTC Therapeutics Inc. - Key offerings
Exhibits 153: Sanofi - Overview
Exhibits 154: Sanofi - Business segments
Exhibits 155: Sanofi - Key news
Exhibits 156: Sanofi - Key offerings
Exhibits 157: Sanofi - Segment focus
Exhibits 158: Sarepta Therapeutics Inc - Overview
Exhibits 159: Sarepta Therapeutics Inc - Product/Service
Exhibits 160: Sarepta Therapeutics Inc - Key offerings
Exhibits 161: SGPharma Pvt. Ltd. - Overview
Exhibits 162: SGPharma Pvt. Ltd. - Product/Service
Exhibits 163: SGPharma Pvt. Ltd. - Key offerings
Exhibits 164: Viatris Inc. - Overview
Exhibits 165: Viatris Inc. - Business segments
Exhibits 166: Viatris Inc. - Key news
Exhibits 167: Viatris Inc. - Key offerings
Exhibits 168: Viatris Inc. - Segment focus
Exhibits 169: Inclusions checklist
Exhibits 170: Exclusions checklist
Exhibits 171: Currency conversion rates for US$
Exhibits 172: Research methodology
Exhibits 173: Validation techniques employed for market sizing
Exhibits 174: Information sources
Exhibits 175: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global neuromuscular disease therapeutics market: Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc., Brainstorm Cell Therapeutics Inc., Cytokinetics Inc., F. Hoffmann La Roche Ltd., Ionis Pharmaceuticals Inc., Mitsubishi Chemical Corp., Mylan NV, Nippon Shinyaku Co. Ltd., Novartis AG, Pfizer Inc., PTC Therapeutics Inc., Sanofi, Sarepta Therapeutics Inc, SGPharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Viatris Inc., and AFM-Telethon.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is technological advances in neuromuscular disease therapy.'

According to the report, one of the major drivers for this market is the novel approvals for neuromuscular disease therapeutics.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Aquestive Therapeutics Inc.
  • Bausch Health Companies Inc.
  • Biogen Inc.
  • Brainstorm Cell Therapeutics Inc.
  • Cytokinetics Inc.
  • F. Hoffmann La Roche Ltd.
  • Ionis Pharmaceuticals Inc.
  • Mitsubishi Chemical Corp.
  • Mylan NV
  • Nippon Shinyaku Co. Ltd.
  • Novartis AG
  • Pfizer Inc.
  • PTC Therapeutics Inc.
  • Sanofi
  • Sarepta Therapeutics Inc
  • SGPharma Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Troikaa Pharmaceuticals Ltd.
  • Viatris Inc.
  • AFM-Telethon

Related Topics

Related Reports

Global Amyotrophic Lateral Sclerosis Treatment Market 2024-2028 - Product Image

Global Amyotrophic Lateral Sclerosis Treatment Market 2024-2028

  • Report
  • 157 Pages
  • Global
From
Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2023-2027 - Product Image

Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2023-2027

  • Report
  • 154 Pages
  • Global
From
Duchenne Muscular Dystrophy - Pipeline Insight, 2024 - Product Image

Duchenne Muscular Dystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • 200 Pages
  • Global
From
Global Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 221 Pages
  • Global
From
North America Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030 - Product Image

North America Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 112 Pages
  • North America
From

About the Neuromuscular Disease Drug Market

The Neuromuscular Disease Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat diseases of the nervous system. Neuromuscular Disease Drugs are used to treat diseases that affect the muscles, such as muscular dystrophy, myasthenia gravis, and amyotrophic lateral sclerosis (ALS). These drugs can be used to reduce muscle weakness, improve muscle strength, and slow the progression of the disease. Commonly used drugs include corticosteroids, immunosuppressants, and anticholinesterase agents. Some companies in the Neuromuscular Disease Drug market include Biogen, Novartis, Merck, and Pfizer. These companies develop and market drugs to treat neuromuscular diseases, as well as other diseases of the nervous system. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.